Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
98.00    0.10 (0.10%)
Bid:
97.10
Ask:
98.20
Spread: 1.10 (1.133%)
Market Cap: £596.03m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Director Changes

18 Mar 2016 16:59

BACIT LIMITED - Director Changes

BACIT LIMITED - Director Changes

PR Newswire

London, March 18

BACIT Limited (the "Company")

(a closed-ended collective investment scheme established as a company with limited liability under the laws of Guernsey with registered number 55514)

Director Resignation

18 March 2016

The Company announces the resignation of Martin Thomas as a non-executive director of the Company, effective 18 March 2016.

Mr Thomas is chairman of the board of directors of BACIT (UK) Limited, the FCA regulated firm that manages the assets of BACIT Limited. Jeremy Tigue, chairman of BACIT Limited said "Martin has been instrumental in establishing BACIT (UK) Limited having been part of the team that founded BACIT in 2012. His contribution as a director of the fund has been much appreciated, and we look forward to continue working with him as chair of our appointed fund manager in the years to come”.

Company website: www.bacitltd.com

Enquiries:Northern Trust International Fund Administration Services (Guernsey) LimitedEmail: rb235@ntrs.comTel: +44 (0) 1481 745189

Date   Source Headline
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 202412:35 pmRNSSpur provides update on FLT201
8th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20245:28 pmRNSDirector Declaration
3rd Jul 20242:22 pmRNSNotice of AGM
3rd Jul 20247:00 amRNSBeacon raises $170 million in a Series B financing
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20241:03 pmRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 202411:37 amRNSDirector/PDMR Shareholding
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20247:00 amRNSDirector/PDMR Shareholding
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSSyncona adds two oncology companies to portfolio
20th Jun 20247:00 amRNSFinal Results
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 202412:05 pmRNSCreation of Spur Therapeutics
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSQuell provides clinical updates on QEL-001
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20243:18 pmRNSTotal Voting Rights
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20241:51 pmRNSAutolus presents FELIX data at ASCO
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSNotice of Results
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.